GSTM1 and chronic kidney disease: Data from two studies reported a decrease in ESA use and Hb concentrations in pre-dialysis CKD from 2005 to 2011 [4, 10] but, to our knowledge, no study has characterized the patterns of treatment in this population after the 2011 ESA label revision.